D-Deprenyl
Overview[edit]
D-Deprenyl, also known as selegiline, is a monoamine oxidase inhibitor (MAOI) that is primarily used in the treatment of Parkinson's disease and major depressive disorder. It is a selective inhibitor of monoamine oxidase B (MAO-B) at lower doses, which makes it useful in increasing dopamine levels in the brain.
Mechanism of Action[edit]
D-Deprenyl works by inhibiting the activity of the enzyme monoamine oxidase B, which is responsible for the breakdown of dopamine in the brain. By inhibiting this enzyme, D-Deprenyl increases the availability of dopamine, which is beneficial in conditions like Parkinson's disease where dopamine levels are reduced.
Clinical Uses[edit]
D-Deprenyl is primarily used in the management of Parkinson's disease. It is often used as an adjunct therapy to levodopa/carbidopa treatment. In addition to its use in Parkinson's disease, D-Deprenyl is also used in the treatment of major depressive disorder, particularly in patients who do not respond to other treatments.
Side Effects[edit]
Common side effects of D-Deprenyl include nausea, dizziness, insomnia, and orthostatic hypotension. At higher doses, it can lose its selectivity for MAO-B and inhibit monoamine oxidase A (MAO-A) as well, which can lead to more severe side effects and dietary restrictions due to the risk of hypertensive crisis.
Pharmacokinetics[edit]
D-Deprenyl is well absorbed from the gastrointestinal tract and is metabolized in the liver. It has a relatively long half-life, which allows for once-daily dosing in most patients. The metabolites of D-Deprenyl include amphetamine and methamphetamine, which can contribute to its stimulating effects.
History[edit]
D-Deprenyl was first synthesized in the 1960s and was initially investigated for its potential as an antidepressant. Its ability to selectively inhibit MAO-B was discovered later, leading to its use in the treatment of Parkinson's disease.
Related Pages[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
